Attributes | Values |
---|
rdf:type
| |
Description
| - There was no statistical difference between gefitinib and vinorelbine in efficacy in chemotherapy-naïve, unselected elderly patients with advanced NSCLC, but there was better tolerability with gefitinib. Individuals who were EGFR FISH-positive benefited more from vinorelbine than from gefitinib.
- There was no statistical difference between gefitinib and vinorelbine in efficacy in chemotherapy-naïve, unselected elderly patients with advanced NSCLC, but there was better tolerability with gefitinib. Individuals who were EGFR FISH-positive benefited more from vinorelbine than from gefitinib. (en)
- Nebyl pozorován statistický rozdíl v efektu chemoterapie gefitinibem a vinorelbinem u pacientů vyššího věku s pokročilým nemalobuněčným karcinomem plic, ale byla zaznamenána lepší tolerance gefitinibu. Při léčbě EGFR FISH-pozitivních osob bylo lepších výsledků dosažno při použití vinorelbinu než gefitinibu. (cs)
|
Title
| - Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.
- Gefitinib versus vinorelbine v chemoterapii pacientů vyššího věku s pokročilým nemalobuněčným karcinomem (INVITE) : randomizovaná studie fáze II (cs)
- Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study. (en)
|
skos:prefLabel
| - Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.
- Gefitinib versus vinorelbine v chemoterapii pacientů vyššího věku s pokročilým nemalobuněčným karcinomem (INVITE) : randomizovaná studie fáze II (cs)
- Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study. (en)
|
skos:notation
| - RIV/00064211:_____/08:#0000028!RIV09-MZ0-00064211
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00064211:_____/08:#0000028
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - gefitinib; vinorelbin; non-small-cell lunf cancer (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Pešek, Miloš
- Zatloukal, Petr
- Reck, Martin
- Cullen, Michael
- Armour, Alison A.
- Cappuzzo, Frederico
- Crino, Lucio
- Duffield, Emma
- Ford, Hugo
- Ghiorghiu, Serban
- Hirsch, Fred
- Speak, Georgina
- Thomson, Joyce C.
- Varella-Garcia, Marileila
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |